Arrhythmia - Guidelines/Tx Flashcards
Which arrhythmia is irregularly irregular?
Afib
Which arrhythmia is irregularly regular?
A flutter
What is Step 1 of AFib management
- Evaluate the need for acute tx (HR control +/- cardioversion)
- Start anticoag (UFH, LMWH)
What are the signs of hemodynamic instability?
Severe HoTN
Angina
Pulmonary edema
In Step 1 of Afib management, if the pt is hemodynamically unstable, what do we do?
- Cardiovert immediately w/o regard to embolic risk
- Post cardioversion 4 weeks warfarin (INR 2-3) or target selective oral anticoags
In Step 1 of Afib management, if the pt is NOT hemodynamically unstable, what do we do?
DO NOT CARDIOVERT
Proceed w/ controlling ventricular rate using AV node blocking agents
Which class(s) of drugs should be avoided during Step 1 of AFib: HR control?
Class Ia & III
These may allow more impulses to cross AV node –> Inc HR
If LVEF > 40%, which classes of drugs are we looking to use for HR control for Afib?
Class II and IV
Can use digoxin but not really
How are the drugs used in HR Control of Step 1 of Afib administered?
IV bolus + continuous infusion
If LVEF < 40%, which classes of drugs are we looking to use for HR control for Afib?
Digoxin (slow onset though)
IV Amiodarone
What is a risk of using IV Amiodarone for LVEF <40% in Afib?
It may facilitate conversion to NSR –> risk of thromboembolic event if a clot is present
If Afib or Aflutter is precipitate by a state of increased adrenergic tone, ____ resistance may be found and ____ may be a better choice
Digoxin resistance
Beta Blocker is an excellent choice
What is Step 2 for Afib management?
Restoration of sinus rhythm VS. continue ventricular rate control + leave pt in arrhythmia
Restoration of sinus rhythm is associated w/ inc risk of ______
Thromboembolism, because NSR promotes effective atrial contractions, which may dislodge poorly adherent thrombi
What was the outcome of the PIAF trial?
Improvement of symptoms w/ rhythm control (Amiodarone) but higher ADR and hospitalization
What was the outcome of the AFFIRM trial?
Rhythm control offered no survival advantage over rate control
What was the outcome of the STAF trial?
No difference in long-term cardiovascular outcomes between rhythm and rate control
When is it NOT necessary to use anticoag prior to cardioversion, and why?
Afib or Aflutter w/ recent onset (<48 hrs); there hasn’t been enough time for atrial thrombi to form
What role does TEE play in cardioversion?
Determine whether a thrombus is present or not
What do we do if a thrombus is present?
Do not cardiovery until thrombus is gone Continue anticoag (UFH/LMWH + Warfarin until goal INR 2-3 OR can use DARE)
DARE anticoag abbrevieation
dabigatran
apixaban
rivaroxaban
edoxaban
If a thrombus is not present?
Continue heparin during TEE + cardioversion
When is 4 week post-cardioversion necessary if AF<48 hrs?
If the pt has a stroke risk or if AF has occurred in the past or is likely to recur
What are the options for rhythm control?
Direct current cardioversion (DC cardioversion)
AAD (Ia, Ic, III, w/ Ic & III pure K+ blockers working the best)
Which Class III are used for chronic rhythm therapy and NOT acute?
Sotalol
Dronedarone
Which Class III are only used for acute rhythm therapy?
Ibutilide
Which AAD are okay to restore NSR if the pt has structural heard dz?
Amiodarone
Dofetilide
Which AAD are okay to restore NSR as long as the pt doesn’t have structural heart dz?
Ic
Ibutilide
Amiodarone
Dofetilide
If we are not doing rhythm control and are just doing rate control, what are our HR goals?
LVEF < 40% :
- <80 bpm at rest
- <100 bpm during exercise
LVEF > 40% :
<110 bpm at rest
What AV node blocking drug do we use for rate control if LVEF > 40%?
Oral CLass II
Class IV
+/- digoxin
What AV node blocking drug do we use for rate control if LVEF < 40%?
Metoprolol succinate
Carvedilol
+/- digoxin
Prevention of long term consequences in paroxysmal, persistent, or permanent AF - Low risk (CHA2DS2VASc = 0 in men, 1 in women)
Reasonable to omit therapy
Prevention of long term consequences in paroxysmal, persistent, or permanent AF - Medium risk (CHA2DS2VASc = 1 in men, 2 in women)
Consider Warfarin (INR 2-3) or DARE
Prevention of long term consequences in paroxysmal, persistent, or permanent AF - High risk (CHA2DS2VASc = 2+ in men, 3+ in women)
Start Warfarin (INR 2-3) or DARE